Meeder Asset Management Inc. Makes New Investment in CVS Health Corporation $CVS

Posted by Brian Himes on Aug 18th, 2026

Meeder Asset Management Inc. purchased a new position in shares of CVS Health Corporation (NYSE:CVS – Free Report) during the 2nd quarter, HoldingsChannel reports. The firm purchased 55,105 shares of the pharmacy operator’s stock, valued at approximately $5,701,000.

Several other institutional investors and hedge funds have also modified their holdings of CVS. BlackRock Inc. bought a new position in CVS Health during the second quarter valued at about $12,747,462,000. Vanguard Group Inc. boosted its stake in shares of CVS Health by 1.5% during the 4th quarter. Vanguard Group Inc. now owns 120,709,530 shares of the pharmacy operator’s stock worth $9,579,508,000 after acquiring an additional 1,824,424 shares in the last quarter. State Street Corp boosted its stake in shares of CVS Health by 2.1% during the 4th quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock worth $4,776,182,000 after acquiring an additional 1,245,457 shares in the last quarter. Capital International Investors increased its holdings in shares of CVS Health by 3.4% during the 4th quarter. Capital International Investors now owns 27,592,356 shares of the pharmacy operator’s stock valued at $2,189,793,000 after acquiring an additional 900,153 shares during the last quarter. Finally, Norges Bank bought a new position in shares of CVS Health in the 4th quarter valued at approximately $1,666,265,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insider Transactions at CVS Health

In other news, Director Larry Robbins sold 370,462 shares of the business’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $93.45, for a total transaction of $34,619,673.90. Following the transaction, the director owned 4,824,799 shares in the company, valued at approximately $450,877,466.55. The trade was a 7.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.85% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

CVS has been the subject of several analyst reports. Barclays boosted their target price on CVS Health from $106.00 to $108.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Wells Fargo & Company lifted their price target on shares of CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a research report on Monday, July 13th. Wall Street Zen upgraded shares of CVS Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 8th. TD Cowen upped their price objective on shares of CVS Health from $105.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, May 11th. Finally, HSBC reiterated a “hold” rating and issued a $103.00 target price on shares of CVS Health in a research note on Monday, July 6th. Twenty-two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $106.75.

Get Our Latest Analysis on CVS

CVS Health Stock Down 3.3%

Shares of CVS stock opened at $93.99 on Tuesday. CVS Health Corporation has a 12 month low of $69.40 and a 12 month high of $110.68. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The firm has a market cap of $120.21 billion, a PE ratio of 24.87, a price-to-earnings-growth ratio of 0.93 and a beta of 0.61. The stock has a 50 day moving average of $102.46 and a 200-day moving average of $88.41.

CVS Health (NYSE:CVS – Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. During the same quarter last year, the company posted $1.81 earnings per share. CVS Health’s quarterly revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, equities analysts predict that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 2.8%. The ex-dividend date was Thursday, July 23rd. CVS Health’s dividend payout ratio (DPR) is currently 70.37%.

CVS Health Company Profile

(Free Report)

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.